151 related articles for article (PubMed ID: 9794244)
1. Combined effects of insulin and dexamethasone on cyclic AMP phosphodiesterase 3 and glycogen metabolism in cultured rat hepatocytes.
Hermsdorf T; Dettmer D
Cell Signal; 1998 Oct; 10(9):629-35. PubMed ID: 9794244
[TBL] [Abstract][Full Text] [Related]
2. Effects of dexamethosone and glucagon after long-term exposure on cyclic AMP phosphodiesterase 4 in cultured rat hepatocytes.
Hermsdorf T; Richter W; Dettmer D
Cell Signal; 1999 Sep; 11(9):685-90. PubMed ID: 10530877
[TBL] [Abstract][Full Text] [Related]
3. Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phosphodiesterase activity.
Shafiee-Nick R; Pyne NJ; Furman BL
Br J Pharmacol; 1995 Aug; 115(8):1486-92. PubMed ID: 8564209
[TBL] [Abstract][Full Text] [Related]
4. OPC-13013, a cyclic nucleotide phosphodiesterase type III, inhibitor, inhibits cell proliferation and transdifferentiation of cultured rat hepatic stellate cells.
Shimizu E; Kobayashi Y; Oki Y; Kawasaki T; Yoshimi T; Nakamura H
Life Sci; 1999; 64(23):2081-8. PubMed ID: 10372650
[TBL] [Abstract][Full Text] [Related]
5. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
Lavan BE; Lakey T; Houslay MD
Biochem Pharmacol; 1989 Nov; 38(22):4123-36. PubMed ID: 2480793
[TBL] [Abstract][Full Text] [Related]
6. The effects of increased cAMP content on inflammation, oxidative stress and PDE4 transcripts during Brucella melitensis infection.
Erdogan S; Aslantas O; Celik S; Atik E
Res Vet Sci; 2008 Feb; 84(1):18-25. PubMed ID: 17397885
[TBL] [Abstract][Full Text] [Related]
7. The use of selective inhibitors and computer modelling to evaluate the role of specific high affinity cyclic AMP phosphodiesterases in the hormonal regulation of hepatocyte intracellular cyclic AMP concentrations.
Houslay MD
Cell Signal; 1990; 2(1):85-98. PubMed ID: 2176803
[TBL] [Abstract][Full Text] [Related]
8. Effects of phosphodiesterase inhibitors, imidazole and phosphate on cyclic CMP phosphodiesterase are different from those on cyclic AMP and cyclic GMP phosphodiesterases.
Kuo JF; Shoji M; Brackett NL; Helfman DM
J Cyclic Nucleotide Res; 1978 Dec; 4(6):463-74. PubMed ID: 85641
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of a phosphodiesterase III in the lysis-sensitive target-induced elevation of cyclic AMP (cAMP) in human natural killer cells.
Whalen MM; Crews JD
Biochem Pharmacol; 2000 Aug; 60(4):499-506. PubMed ID: 10874124
[TBL] [Abstract][Full Text] [Related]
10. Long-term hormonal regulation of the cAMP-specific phosphodiesterases in cultured FRTL-5 thyroid cells.
Takahashi SI; Nedachi T; Fukushima T; Umesaki K; Ito Y; Hakuno F; Van Wyk JJ; Conti M
Biochim Biophys Acta; 2001 Jul; 1540(1):68-81. PubMed ID: 11476896
[TBL] [Abstract][Full Text] [Related]
11. Cyclic AMP phosphodiesterases of human and rat islets of Langerhans: contributions of types III and IV to the modulation of insulin secretion.
Parker JC; VanVolkenburg MA; Ketchum RJ; Brayman KL; Andrews KM
Biochem Biophys Res Commun; 1995 Dec; 217(3):916-23. PubMed ID: 8554616
[TBL] [Abstract][Full Text] [Related]
12. Changes in hormone responsiveness and cyclic AMP metabolism in rat hepatocytes during primary culture and effects of supplementing the medium with insulin and dexamethasone.
Christoffersen T; Refsnes M; Brønstad GO; Ostby E; Huse J; Haffner F; Sand TE; Hunt NH; Sonne O
Eur J Biochem; 1984 Jan; 138(2):217-26. PubMed ID: 6321168
[TBL] [Abstract][Full Text] [Related]
13. Type IV phosphodiesterase activity specifically regulates cAMP-stimulated casein secretion in the rat mammary gland.
Pooley L
Biochim Biophys Acta; 2002 Jun; 1590(1-3):84-92. PubMed ID: 12063171
[TBL] [Abstract][Full Text] [Related]
14. New insight into the role of phosphodiesterase 3A in porcine oocyte maturation.
Sasseville M; Côté N; Guillemette C; Richard FJ
BMC Dev Biol; 2006 Oct; 6():47. PubMed ID: 17038172
[TBL] [Abstract][Full Text] [Related]
15. Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis.
Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D
Cell Signal; 2001 Mar; 13(3):159-67. PubMed ID: 11282454
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of cAMP-specific PDE-4 activity following ligation of the TCR complex on thymocytes is blocked by selective inhibitors of protein kinase C and tyrosyl kinases.
Michie AM; Rena G; Harnett MM; Houslay MD
Cell Biochem Biophys; 1998; 28(2-3):161-85. PubMed ID: 9515165
[TBL] [Abstract][Full Text] [Related]
17. Effect of type-selective inhibitors on cyclic nucleotide phosphodiesterase activity and insulin secretion in the clonal insulin secreting cell line BRIN-BD11.
Ahmad M; Abdel-Wahab YH; Tate R; Flatt PR; Pyne NJ; Furman BL
Br J Pharmacol; 2000 Mar; 129(6):1228-34. PubMed ID: 10725272
[TBL] [Abstract][Full Text] [Related]
18. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
Eckly AE; Lugnier C
Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
[TBL] [Abstract][Full Text] [Related]
19. Engineered deletion of the unique N-terminal domain of the cyclic AMP-specific phosphodiesterase RD1 prevents plasma membrane association and the attainment of enhanced thermostability without altering its sensitivity to inhibition by rolipram.
Shakur Y; Pryde JG; Houslay MD
Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):677-86. PubMed ID: 7686364
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity.
Torphy TJ; Zhou HL; Cieslinski LB
J Pharmacol Exp Ther; 1992 Dec; 263(3):1195-205. PubMed ID: 1335058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
